Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis

Pol J Pathol. 2015 Dec;66(4):420-5. doi: 10.5114/pjp.2015.57257.

Abstract

Between 1990 and 1999, 182 men were treated for non-seminomatous germ cell testicular tumours. In 24 of them after chemotherapy a residual retroperitoneal mass was removed. In 14 of them additional immunohistochemical (IHC) examinations using antibodies against cytokeratins, vimentin, PLAP, CD30, AFP, βhCG, p53, and MIB-1 were performed. We compared the results of those additional studies with the results of routine histopathological examination. Histological assessment revealed most frequently (ca. 54% of cases) non-neoplastic lesions, i.e. fibro-cystic, necrotic or inflammatory tumours and lymphatic tissue. In about 33% of cases, surviving live neoplastic cells were found.

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Immunohistochemistry
  • Male
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Germ Cell and Embryonal / secondary*
  • Retroperitoneal Neoplasms / pathology
  • Retroperitoneal Neoplasms / secondary*
  • Retroperitoneal Space / pathology*
  • Retrospective Studies
  • Testicular Neoplasms / drug therapy
  • Testicular Neoplasms / pathology*

Substances

  • Antineoplastic Agents